Bayer has released the data in its phase 2b trial of eliapixant in refractory chronic ... cough, as it tries to close the gap with Merck & Co's rival drug gefapixant. The pharma company said last ...
The decision comes just a few months after Bayer reported encouraging results for eliapixant in chronic cough – the same indication sought by Merck for gefapixant – saying it hit its objective ...
Good afternoon and welcome to the Trevi Therapeutics3rd Quarter, 2024 earnings conference call. At this time, all participants will be in listen-only mode. (Operator Instruction) Please note this ...
Nonetheless, the data suggest that chronic DBS often produces improved tremor control in multiple sclerosis. Complete cessation of tremor is not necessarily achieved, there are cases in which tremor ...
He spoke to a doctor through his work at healthcare company Teladoc Health, which led to his diagnosis in October this year, seven months after his cough started. It was discovered that he had a 7.8cm ...
He spoke to a doctor through his work at healthcare company Teladoc Health, which led to his diagnosis in October this year, seven months after his cough started. It was discovered that he had a 7 ...
Expert Rev Neurother. 2010;10(3):469-474. Radiofrequency ablation is a common therapeutic modality to treat various types of chronic pain. The use of facet median nerve branch radiofrequency ...
Trigeminal neuralgia, cluster headaches and chronic fascial pain are types of headaches amenable to interventions. Before proceeding with RFA, the practioner performs diagnostic block using local ...